SCHEMBL7952848

SCHEMBL7952848

COc1cc(N)c(Cl)cc1-c1nn(-c2ccc(Cl)c(Cl)c2)c(=O)o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPT P10636 2/20 0.39
NPC1 O15118 2/20 0.38
RIPK2 O43353 1/20 0.37
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
RAB9A P51151 1/20 0.37
GAA P10253 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
RPA1 P27694 1/20 0.36
MAPK1 P28482 1/20 0.36
ESR2 Q92731 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ABHD16A O95870 1/20 0.36
RAD51 Q06609 1/20 0.35
ATM Q13315 1/20 0.35
MGLL Q99685 1/20 0.34
HTR2A P28223 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957435 0.88 LMNA (0.49) LMNASMN1; SMN2NPSR1MAPTNPC1
SCHEMBL5804359 0.84 RPA1 (0.38) LMNASMN1; SMN2NPSR1MAPTKMT2A
SCHEMBL8304880 0.71 HTR4 (0.44) NPC1
SCHEMBL8305104 0.71 HTR4 (0.44) SMN1; SMN2GAA
SCHEMBL5753908 0.71 LMNA (0.42) LMNASMN1; SMN2MAPTKMT2AMEN1
Bromide SCHEMBL8366387 0.70 HTR4 (0.43) NPC1
SCHEMBL7804908 0.70 HTR4 (0.48) NPC1
Hydrochloric Acid SCHEMBL8368070 0.70 HTR4 (0.43) MAPK1
SCHEMBL7808395 0.70 HTR4 (0.45) NPC1
SCHEMBL10475149 0.69 KMT2A (0.46) LMNASMN1; SMN2NPSR1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271249-B1 Diphenyl imidazoles as potassium channel modulators BRISTOL-MYERS SQUIBB COMPANY 2001-08-07 US disclosed
US-6077861-A MODULATORS OF THE LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM (BK) CHANNELS, THEREFORE, USEFUL IN THE TREATMENT OF ISCHEMIC STROKE BRISTOL-MYERS SQUIBB COMPANY (US) 2000-06-20 US disclosed
US-5869509-A TREAT DISORDERS RESPONSIVE TO OPENERS OF THE LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-02-09 US disclosed